Gynecologic Cancer
News
Photodynamic therapy looks promising in early CIN
Major finding: Patients with CIN2 were significantly more likely to have a response when treated with the highest dose of HAL photodynamic therapy...
News
Retroperitoneal exploration extends survival in stage IIIc ovarian cancer
Major finding: Median progression-free survival was better (18.5 vs. 16.0 months, P less than .0001) and overall survival was longer (53.3 vs.
News
CA125 level predicts microscopic residual disease in ovarian cancer
Major finding: The higher the preoperative CA125 level, the lower the predicted probability of achieving microscopic residual disease.
News
Cyberknife therapy offers benefits for recurring gyn cancers
Major finding: The 6-month clinical benefit rate was 68%. Higher-severity acute adverse events were uncommon.Data source: A phase II trial among...
News
Racial genetic admixture linked to endometrial cancer outcomes
Major finding: The risk of progression or death rose by 2% with each 1% increase in African racial genetic admixture and fell by 3% with each 1%...
News
Immunotherapy boosts response in recurrent ovarian cancer
Major finding: A two-step immunotherapy regimen combined with chemotherapy had up to a 75% response rate for women with recurrent stage III or IV...
News
HPV testing best predicts cervical neoplasia risk
Major Finding: The 3-year cumulative incidence rate of CIN3 or more advanced neoplasia was 0.33% in women negative for high-risk HPV and 0.77% in...
News
Guideline nonadherence linked to increased ovarian cancer deaths
Major finding: In multivariate analyses, patients had significantly higher odds of ovarian cancer death if they received nonadherent treatment (...
News
Lipid metabolism genes linked to breast cancer subtype
Major finding: A clustering analysis of eight genes separated cases into expression groups; 70% of the low-expression cases had ER-positive tumors...
News
Bevacizumab plus chemo extends survival in metastatic cervical cancer
Major Finding: Patients with recurrent, persistent, or metastatic cervical cancer who were randomized to a chemotherapy regimen including...